查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1433394

全球皮膚切片市場 2023-2030

Global Skin Biopsy Market 2023-2030
出版日期: | 出版商: Orion Market Research | 英文 115 Pages | 商品交期: 2-3個工作天內

價格

預計在預測期內（2023-2030年），全球皮膚切片市場將以6.8%的複合CAGR成長。市場的成長歸因於對先進護膚產品的需求。消費者對高品質護膚產品的需求持續成長，尤其是那些採用科學驗證的顯著成分（如透明質酸、胜肽和抗氧化劑）設計的產品。新產品的推出激發了護膚界的興趣和調查。例如，2022年12月，Hydrinity Accelerated Skin Science推出了新的臉部護膚系列，其中含有眾所周知的透明質酸（HA）成分、PPM技術以及多種胜肽和抗氧化劑。新的護膚系列包括更新的透明質酸精華液、保濕和修復精華液，以及輕盈、有益於微生物組的淨化噴霧，所有這些都目的是減少衰老跡象、改善膚質並加速皮膚癒合。然而，皮膚活體組織切片的高成本可能會限制其在低收入經濟體的成長。

細分市場前景

全球皮膚切片市場依類型、適應症和最終用戶進行細分。根據類型，市場分為刮取活體組織切片、穿刺活體組織切片和切除活體組織切片。根據適應症，市場細分為皮膚癌診斷和分期、光化性角化病、皮膚炎等。此外，根據最終用戶，市場細分為醫院、診斷實驗室等。皮膚癌診斷和分期子類別預計將佔據適應症領域的很大一部分市場佔有率。這種成長可歸因於皮膚癌盛行率的增加，以及皮膚病的診斷較早。此外，皮膚癌需要盡快檢測和治療，以避免在危險的黑色素瘤或其他皮膚癌的情況下需要手術。

診斷實驗室細分市場預計將在全球皮膚活體組織切片市場中佔據相當大的佔有率

在最終用戶中，診斷實驗室細分市場預計將在全球皮膚活體組織切片市場中佔據相當大的佔有率。細分市場的成長歸功於創新的診斷方法。使用皮膚切片樣本診斷阿茲海默症是神經學領域的創新方法。這些創新方法拓寬了皮膚活體組織切片在皮膚科以外的應用，有助於皮膚活體組織切片行業的多元化。例如，2023年2月，SynapsDx準備推出基於皮膚的阿茲海默症診斷測試​​。 Synaps 使用三種生物標記來診斷阿茲海默症並將其與其他失智症類型區分開來。主要診斷基於形態測量成像，該成像測量患者皮膚樣本中成纖維細胞的細胞生長。阿茲海默症患者的大聚集體較少。

區域展望

全球皮膚切片市場根據地理位置進一步細分，包括北美（美國和加拿大）、歐洲（英國、義大利、西班牙、德國、法國和歐洲其他地區）、亞太地區（印度、中國、日本、韓國和亞洲其他地區），以及世界其他地區（中東和非洲以及拉丁美洲）。其中，由於皮膚健康意識的增強，預計亞太地區將在全球市場中佔據顯著佔有率，預計診斷和治療過程將在整個預測期內推動市場發展。

考慮到全球皮膚活體組織切片市場，北美保持不變

目錄

第1章 報告摘要

  • 目前行業分析及成長潛力展望
  • 研究方法和工具
  • 市場區隔
    • 依細分
    • 依地區

第2章 市場概述與見解

  • 報告範圍
  • 分析師見解和當前市場趨勢
    • 主要發現
    • 建議
    • 結論

第3章 競爭格局

  • 主要公司分析
  • Cardinal Health, Inc.
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • Becton, Dickinson, and Co.
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • Bio-Rad Laboratories, Inc.
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展

第4章 市場細分

  • 依類型分類的全球皮膚活體組織切片市場
    • 刮取活體組織切片
    • 穿刺活體組織切片
    • 切除活體組織切片
  • 按適應症分類的全球皮膚切片市場
    • 皮膚癌的診斷和分期
    • 光化性角化症
    • 皮膚炎
    • 其他（頭髮和指甲疾病以及自體免疫性皮膚疾病）
  • 依最終用戶分類的全球皮膚活體組織切片市場
    • 醫院
    • 診斷實驗室
    • 其他（研究機構和學術中心、皮膚科醫生和病理學家）

第5章 區域分析

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 歐洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 世界其他地區

第6章 公司簡介

  • AccuTec, Inc.
  • Danaher Corp.
  • Hologic, Inc.
  • Innovia Medical
  • Integra LifeSciences
  • Jai Surgicals Ltd.
  • Kai Corp.
  • NIKON CORP.
  • Paramount Surgimed Ltd.
  • PerkinElmer U.S. LLC
  • Roche Diagnostics India Pvt. Ltd.
  • Stryker Corp.
  • Thermo Fisher Scientific Inc.
  • Vernacare
  • World Precision Instruments
  • Sysmex Corp.
  • Bruker Corp.
  • Illumina, Inc.
Product Code: OMR2027970

Global Skin Biopsy Market Size, Share &Trends Analysis Report by Type (Shave Biopsy, Punch Biopsy, and Excisional Biopsy), by Indication (Skin Cancer Diagnosis and Staging, Actinic keratosis, Dermatitis, and Others) and by End-User (Hospitals, Diagnostic Laboratories, and Others), Forecast Period (2023-2030)

The global skin biopsy market is anticipated to grow at a considerable CAGR of 6.8% during the forecast period (2023-2030).The market's growth is attributed to the demand for advanced skincare products. Consumer demand for high-quality skincare products, particularly those designed with prominent and scientifically validated components such as HA, peptides, and antioxidants, continues to rise. The launch of new products stimulates interest and investigation in the skincare sector. For instance, in December 2022, Hydrinity Accelerated Skin Science launched new facial skin care line with well-known ingredients of hyaluronic acid (HA), PPM technology, and numerous peptides and antioxidants. The new skin care line includes a renewing HA serum, a hydrating and healing serum, and a lightweight, microbiome-friendly purifying mist, all designed to reduce signs of aging, improve texture, and accelerate skin healing. However, the high cost of skin biopsy may restrain its growth in low-income economies.

Segmental Outlook

The global skin biopsy market is segmented on the type, indication, and end-user. Based on the type, the market is sub-segmented into shave biopsy, punch biopsy, and excisional biopsy. Based on the indication, the market is sub-segmented into skin cancer diagnosis and staging, actinic keratosis, dermatitis, and others. Furthermore, on the basis of end-user, the market is sub-segmented into hospitals, diagnostic laboratories, and others. The skin cancer diagnosis and staging subcategory is expected to capture a significant portion of the market share within the indication segment. The growth can be attributed to the skin cancer prevalence is increasing, and skin diseases have been diagnosed earlier. In addition, skin cancer needs to be detected and treated as soon as possible to avoid the need for surgery in the case of a dangerous melanoma or other skin cancer.

Diagnostic Laboratories Sub-Segment is Anticipated to Hold a Considerable Share of the global Skin Biopsy Market

Among the end-user, the diagnostic laboratories sub-segment is expected to hold a considerable share in the global Skin Biopsy market. The segmental growth is attributed to the innovative diagnostic approaches. The use of skin biopsy samples to diagnose Alzheimer's disease is an innovative method in neurology. Such innovative approaches broaden the applications of skin biopsies outside dermatology, helping to diversify the skin biopsy industry. For instance, in February 2023, SynapsDx Prepares Launched Skin-Based Alzheimer's Disease Diagnostic Test. Synaps uses three biomarkers to diagnose Alzheimer's disease and differentiate it from other dementia forms. The primary diagnosis is based on morphometric imaging, that measures cell growth in fibroblasts from a patient's skin sample. Alzheimer's patients have fewer large aggregates.

Regional Outlook

The global skin biopsy market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Asia-Pacific is anticipated to hold a prominent share of the market across the globe, owing to increased awareness of skin health, diagnosis, and treatment processes is expected to drive the market throughout the forecast period.

The North America Holds Considering the global Skin Biopsy Market

Regional growth is attributed to the medical need for pediatric skin biopsies. The observations highlight the importance of skin biopsies in the diagnosis of pediatric skin disorders. As a result children and adolescents account for a sizable proportion of biopsy cases, the demand for biopsy equipment and services tailored to younger patients has the potential to drive market expansion.

According to the National Institute of Government, in June 2023, a study analyzed 1308 biopsy records, revealing a male predominance and a majority of patients were adolescents. Furthermore, study found that 12.9% of pediatric skin biopsies were performed, with 83.9% of patients underwent a single biopsy. The majority of patients underwent multiple biopsies, with 98% performing a biopsy for diagnostic purposes. The mean age of patients was 12 years, with males outnumbering females. The study emphasizes the importance of skin biopsies in pediatric patients and the high clinic-histopathologic agreement. Leprosy and papulosquamous diseases were the most common cases.

Market Players Outlook

The major companies serving the skin biopsy market includes Cardinal Health Inc., AccTec Inc., Beckton, Dickenson, and Company, Bio-Rad Laboratories Inc., and Kai Group among others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market.

For instance in June 2019,Proscia Launched DermAI to Pre-Screen and Classify Skin Biopsies. Proscia's AI-powered software can classify skin disease variants into pre-diagnostic categories, enhancing pathology confidence, quality, and speed, reducing errors and improving laboratory efficiency.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global skin biopsy market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies. Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Cardinal Health, Inc.
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Becton, Dickinson, and Co.
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Bio-Rad Laboratories, Inc.
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments

4. Market Segmentation

  • 4.1. Global Skin Biopsy Market by Type
    • 4.1.1. Shave Biopsy
    • 4.1.2. Punch Biopsy
    • 4.1.3. Excisional Biopsy
  • 4.2. Global Skin Biopsy Market by Indication
    • 4.2.1. Skin Cancer Diagnosis and Staging
    • 4.2.2. Actinic Keratosis
    • 4.2.3. Dermatitis
    • 4.2.4. Others (Hair and Nail Disorders, and Autoimmune Skin Disorders)
  • 4.3. Global Skin Biopsy Market by End-User
    • 4.3.1. Hospitals
    • 4.3.2. Diagnostic Laboratories
    • 4.3.3. Others (Research Institutions and Academic Centers, Dermatologists and Pathologists)

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. AccuTec, Inc.
  • 6.2. Danaher Corp.
  • 6.3. Hologic, Inc.
  • 6.4. Innovia Medical
  • 6.5. Integra LifeSciences
  • 6.6. Jai Surgicals Ltd.
  • 6.7. Kai Corp.
  • 6.8. NIKON CORP.
  • 6.9. Paramount Surgimed Ltd.
  • 6.10. PerkinElmer U.S. LLC
  • 6.11. Roche Diagnostics India Pvt. Ltd.
  • 6.12. Stryker Corp.
  • 6.13. Thermo Fisher Scientific Inc.
  • 6.14. Vernacare
  • 6.15. World Precision Instruments
  • 6.16. Sysmex Corp.
  • 6.17. Bruker Corp.
  • 6.18. Illumina, Inc.

LIST OF TABLES

  • 1. GLOBAL SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 2. GLOBAL SHAVE SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
  • 3. GLOBAL PUNCH SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
  • 4. GLOBAL EXCISIONAL SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
  • 5. GLOBAL SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY INDICATION, 2022-2030 ($ MILLION)
  • 6. GLOBAL SKIN BIOPSY IN SKIN CANCER DIAGNOSIS AND STAGING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 7. GLOBAL SKIN BIOPSY IN ACTINIC KERATOSIS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 8. GLOBAL SKIN BIOPSY IN DERMATITIS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 9. GLOBAL SKIN BIOPSY IN OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 10. GLOBAL SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 11. GLOBAL SKIN BIOPSY FOR HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 12. GLOBAL SKIN BIOPSY FOR DIAGNOSTIC LABORATORIES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 13. GLOBAL SKIN BIOPSY FOR OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 14. GLOBAL SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 15. NORTH AMERICAN SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 16. NORTH AMERICAN SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 17. NORTH AMERICAN SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY INDICATION, 2022-2030 ($ MILLION)
  • 18. NORTH AMERICAN SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 19. EUROPEAN SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 20. EUROPEAN SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 21. EUROPEAN SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY INDICATION, 2022-2030 ($ MILLION)
  • 22. EUROPEAN SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 23. ASIA- PACIFIC SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 24. ASIA- PACIFIC SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 25. ASIA- PACIFIC SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY INDICATION, 2022-2030 ($ MILLION)
  • 26. ASIA- PACIFIC SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 27. REST OF THE WORLD SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 28. REST OF THE WORLD SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 29. REST OF THE WORLD SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY INDICATION, 2022-2030 ($ MILLION)
  • 30. REST OF THE WORLD SKIN BIOPSY MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL SKIN BIOPSY MARKET SHARE BY TYPE, 2022 VS 2030 (%)
  • 2. GLOBAL SHAVE SKIN BIOPSY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL PUNCH SKIN BIOPSY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL PUNCH SKIN BIOPSY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 5. GLOBAL SKIN BIOPSY MARKET SHARE BY INDICATION, 2022 VS 2030 (%)
  • 6. GLOBAL SKIN BIOPSY IN SKIN CANCER DIAGNOSIS AND STAGING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 7. GLOBAL SKIN BIOPSY IN ACTINIC KERATOSIS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 8. GLOBAL SKIN BIOPSY IN DERMATITIS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL SKIN BIOPSY IN OTHERS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 10. GLOBAL SKIN BIOPSY MARKET SHARE BY END-USER, 2022 VS 2030 (%)
  • 11. GLOBAL SKIN BIOPSY FOR HOSPITALS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 12. GLOBAL SKIN BIOPSY FOR DIAGNOSTIC LABORATORIES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 13. GLOBAL SKIN BIOPSY FOR OTHERS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 14. GLOBAL SKIN BIOPSY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 15. US SKIN BIOPSY MARKET SIZE, 2022-2030 ($ MILLION)
  • 16. CANADA SKIN BIOPSY MARKET SIZE, 2022-2030 ($ MILLION)
  • 17. UK SKIN BIOPSY MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. FRANCE SKIN BIOPSY MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. GERMANY SKIN BIOPSY MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. ITALY SKIN BIOPSY MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. SPAIN SKIN BIOPSY MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. REST OF EUROPE SKIN BIOPSY MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. INDIA SKIN BIOPSY MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. CHINA SKIN BIOPSY MARKET SIZE, 2022-2030 ($ MILLION)
  • 25. JAPAN SKIN BIOPSY MARKET SIZE, 2022-2030 ($ MILLION)
  • 26. SOUTH KOREA SKIN BIOPSY MARKET SIZE, 2022-2030 ($ MILLION)
  • 27. REST OF ASIA-PACIFIC SKIN BIOPSY MARKET SIZE, 2022-2030 ($ MILLION)
  • 28. REST OF THE WORLD SKIN BIOPSY MARKET SIZE, 2022-2030 ($ MILLION)